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INTRODUCTION
Chronic lymphocytic leukemia (CLL) is a malignant
lymphoproliferative disorder characterized in 98% of the
cases by clonal expansion of B lymphocytes CD 5, CD 19
and CD 23 positive.
Cytogenetic study is important in prognosis, but may
depend on disease stage (Zwiebel and Cheson, 1998). The
most frequent abnormalities found, totaling 60%, are trisomy
12, t(14q), t/del(13q), del(6q) and 11q22-23 (Hallek et al.,
1997; Juliusson and Merup, 1998). Patients with chromo-
somal abnormalities, particularly when complex, have shorter
survival (Escudier et al., 1993; Xue et al., 1993) while those
with normal karyotypes respond significantly better to che-
motherapy (Han et al., 1988). Karyotype evolution has been
observed in 20% of the cases and generally in Richter’s trans-
formation (Robert et al., 1982; Tsujimoto et al., 1985; Giles
et al., 1998).
Chromosomal abnormalities are found by conventional
G-banding in only 50% of the patients (Hallek et al., 1997).
Some difficulties exist in obtaining mitosis in CLL due to
low mitotic index or because metaphases are not always part
of the malignant clone. Since the introduction of molecular
cytogenetics (FISH), applying centromeric probes for chro-
mosome 12 (alpha satellite) has made possible the detection
of a higher percentage of trisomy 12 cases (Hamblin, 1997).
The objective of the present study was to detect tri-
somy 12 by FISH in 13 patients whose chromosomal analy-
sis by conventional G-banding was either normal or failed.
MATERIAL  AND METHODS
Thirteen CLL patients with normal karyotypes or with-
out results due to lack of metaphases were studied. Table I
shows some diagnostic data. The control group was consti-
tuted of 3 bone marrow donors with normal karyotypes.
The CLL diagnosis resulted from the presence of ab-
solute lymphocyte count greater than 5,000/dl, bone mar-
row aspiration showing infiltration by lymphoproliferative
cells, phenotyping with CD 5, CD 23 and SIg positive cells,
and bone marrow biopsy showing massive lymphocyte in-
filtration (Brittinger et al., 1997).
Study of karyotype was done using peripheral blood
whose buffy coat was divided and placed in 2 culture flasks
with 8 ml RPMI 1640 medium, pH 7.2, 20% fetal calf se-
rum, 1% antibiotics and 100 µl L-glutamin. To the first flask
it was added Pokeweed mitogen (0.1 mg/ml) and, to the
second, phorbol 12-myristate 13 acetate (TPA, 50 ng/ml)
and PHA (0.1 mg/ml) for 72 h. Colcemid was added during
the last 60 min followed by hypotonic treatment with 0.075
mol/l KCl for 20 min and fixation with methanol and acetic
acid (3:1) solution repeated 4 times.
The slides were banded for trypsin G-banding (GTG);
10 metaphases from each culture were analyzed. Chromo-
somal abnormalities were described following ISCN (1995).
Part of fixed cell (0.5 ml) suspension was separated
for FISH. This material was centrifuged again and resus-
pended; the slides were made by cytocentrifuging (Incibras).
After air drying, these slides were washed in 2X SSC for 30
min at 37oC and dehydrated in 70, 80 and 95% ethanol for 2
min in each. The probe for chromosome 12 alpha satellite
D1273 (Oncor) (1.5 µl) was mixed with 30 µl hybrisol VI
(Oncor), both previously heated to 37oC, for 5 min. The
probe mixture was then denatured at 72oC for 5 min,
dropped into the cytospin smear, coverslipped, sealed with
rubber cement and incubated for 16 h in a humidified cham-
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ber at 37oC. Detection and signal amplification were made
by removing coverslip, rinsing the slides in 0.25X SSC
for 5 min at 72oC and phosphate-buffered detergent (PBD)
for 2 min at 37oC. Incubation continued with FITC-labeled
antidigoxigenin for 5 min at 37oC covered with plastic cov-
erslip. They were then rinsed three times in PBD for 2 min
and incubated with 20 µl rabbit antisheep antibody for 15
min at 37oC. The slides were washed three times in PBD,
then incubated with 20 µl FITC antirabbit antibody, for 15
min at 37oC, coverslipped. After three PBD washes, 10 µl
propidium iodide with antifade (0.3 µg/ml) was added and
the slides were again coverslipped. They were then analyzed
with a fluorescent microscope (Olympus BMX60) with
FITC and rhodamine filters (Chroma Technologies). The
images were captured through a CCD camera (Cohu) as-
sembled to a computer having karyotyping and FISH soft-
ware (CytoVision-Applied Imaging). Slides showing more
than 50% cells with fluorescent dots were selected for
analysis. From each slide at least 200 cells were counted
and all of them isolated to avoid overlapping signals (Fig-
ure 1).
RESULTS
Table II shows FISH analysis results of the 13 patients
and controls. Each fluorescent dot in a cell represents 12
chromosome centromere (Figure 1).
Patients 4, 11 and 13 presented trisomy 12 with 55.5,
79 and 62% of positive cells, respectively.
In the control group the mean of 1.16 cells with three
fluorescent dots was observed, and normal range was de-
fined as from 0 to 3.24 cells (two standard deviations).
DISCUSSION
The main problem in karyotype study in CLL is the dif-
Figure 1 - FISH of case 11. The interphase cells present 3 fluorescent signals.
Table I - Patient diagnostic data.
Sex Age Date of diagnosis Stage Chemotherapy ∆ts/qt L x 109/dl
1 F 46 9/93 B S 1 9.000
2 F 60 8/95 A N - 17.000
3 F 86 11/93 B S 3 18.900
4 M 60 7/94 A N - 17.000
5 M 77 5/94 A N - 42.000
6 M 70 5/97 A N - 21.000
7 F 72 5/98 B S 3 27.000
8 F 70 1/92 A S 4 56.000
9 M 73 3/98 C S 1 39.000
10 F 83 9/99 A N - 12.000
11 M 60 2/99 C N - 85.000
12 F 83 5/69 C S 2 98.000
13 M 68 1/92 C S 2 58.000
F = Female; M = male; ∆ts/qt = period of time without chemotherapy in years; L x 109/dl =
lymphocytes total count /dl.
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ficulty in obtaining B lymphocyte in mitotic division, even
using B cell mitogens like PWM or TPA (Hamblin, 1997).
Chromosomal abnormalities are described varying
from 20 to 70% of CLL cases, occurring more frequently
in patients with advanced stages of the disease (Zwiebel and
Cheson, 1998).
The FISH method is sensitive and highly specific for
trisomy 12 detection; subsequent to its implementation the
number of cases reported with this abnormality increased
around 10%, varying from 12 to 42.6% (Nair et al., 1998).
In the present report we detected trisomy 12 in 3 (around
23%) out of 13 patients whose karyotypes were normal or
failed.
A variation in the percentage of cells with trisomy 12
detected by FISH has been reported and some authors have
divided it into two groups: one with small percentage (<10%)
and the other with high percentage (>10%). The second group
correlates with a more advanced disease stage and, conse-
quently, trisomy 12 would relate to an ongoing event (Reed,
1998; Nair et al., 1998).
A trisomy 12 and atypical morphology correlation was
suggested (nucleous cleavage, lymphoplasmatic character-
istics and increased prolymphocyte number) (Matutes et
al., 1996) but no correlation with disease stage has been
observed.
Case 4 showed increased CD 20 intensity and surface
IgM in phenotyping. Great immunological marker variabil-
ity has been described in CLL with trisomy 12, though no
specific pattern exists (Döhner et al., 1997).
In conclusion, detecting trisomy 12 by FISH was pos-
sible in 3 patients (around 23%) with normal or unsuccessful
karyotype showing that FISH should be used as a routine test
in addition to karyotype. More extensive studies are needed
to better estimate frequency of this abnormality in patients.
RESUMO
A leucemia linfocítica crônica (CLL) apresenta incidência
variável de anomalias de cariótipo devido às dificuldades em se
obter mitose para análise. Desde a introdução da citogenética mo-
lecular (FISH = hibridação in situ por fluorescência) usando sonda
centromérica para o cromossomo 12 foi possível detectar uma maior
porcentagem de casos com trissomia 12. O objetivo deste trabalho
foi de detectar trissomia 12 por FISH (sonda alfa satélite) em 13
pacientes com CLL cujos cariótipos por banda G haviam sido
normais ou sem resultado. Três pacientes apresentaram trissomia
12 por este método com uma porcentagem de células trissômicas
variando de 55,5 a 79%, demonstrando que a FISH é um método
sensível e altamente específico para detecção de trissomia 12.
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Table II - Results of FISH analysis.
    Case 3 signals 2 signals
1 1% 98% 
2 2% 91%
3 3% 90%
4 55.5% 42%
5 0 94.3%
6 2.5 94%
7 0 93.3%
8 2.5 94%
9 3 91%
10 0 98%
11 79% 18.6%
12 2.3 92%
13 62% 36%
Control 1 4 (2%) 188 (94%)
Control 2 0 189 (94.5%)
Control 3 3 (1.5%) 194 (97%)
X 1.16 95.16
SD 0-3.24 91.96-98.36
3 signals = Visualization of 3 fluorescent signals in
cell; 2 signals = visualization of 2 fluorescent sig-
nals in cell; X = mean; SD = standard deviation.
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